PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation

Recruiting now

Conditions studied: Atrial Fibrillation

In brief

Atrial fibrillation ablation is the most common intervention performed worldwide. Up to 20 to 45% of patients show recurrence of AF within 12 month after catheter ablation, however its determinant are incompletely understood. The aim of the PROSPECT-AF study is to assess the predictors of AF recurrence within the 3 years following ablation using clinical variables and innovative biomarkers in a prospective cohort of 750 patients undergoing atrial fibrillation catheter ablation. The secondary aims are to assess the incidence of major adverse cardiovascular outcomes (MACE) and the incidence of major bleeding within the 3 years Wolfing catheter ablation.

Key facts

Study ID

NCT05009797

Run by

University Hospital, Lille

People needed

750

Starts

2023-02-16

Expected to finish

2031-02-01

Last updated by the study team

2026-04-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient undergoing atrial fibrillation catheter ablation
• Able to give their consent

You may not qualify if…

• Childs
• Patient under guardianship
• Patients unable to give their consent
• Pregnancy

Where it is running

• Institut Coeur-Poumon, CHU — Lille, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.